Laden…
(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Al-LAD is a semi-synthetic lysergamide and primarily acts as an agonist at the 5-HT2A receptor. It induces psychedelic effects that may include visual and cognitive changes. The substance is pharmacologically related to LSD but exhibits its own effect profile. Risks include psychological distress and potential cardiovascular effects.
Class
Lysergamide
Pharmacological context
Mechanism
Al-LAD primarily acts as an agonist at the 5-HT2A receptor, leading to...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Al-LAD primarily acts as an agonist at the 5-HT2A receptor, leading to the characteristic psychedelic effects. The substance affects serotonergic transmission in the brain and can induce visual as well as cognitive changes.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 100–200 µg
Total duration 8–12 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 50–100 µg |
| Reported | 100–200 µg |
| Strong | 200–300 µg |
Oral
Onset
30–60 minutes
Peak
2–4 hours
Total duration
8–12 hours
After effects
1–3 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Evidence
Begrenzte formale Humandaten. Tiermodelle und Erfahrungsberichte vorhanden. Rechtsstatus variiert — in mehreren Ländern als NPS reguliert.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.